• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种噬菌体鸡尾酒在铜绿假单胞菌鼻窦炎体内模型中的安全性和疗效。

Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis.

机构信息

Department of Surgery - Otolaryngology Head and Neck Surgery, The Queen Elizabeth Hospital, University of Adelaide, Woodville South, South Australia, Australia.

Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.

出版信息

Transl Res. 2019 Apr;206:41-56. doi: 10.1016/j.trsl.2018.12.002. Epub 2018 Dec 19.

DOI:10.1016/j.trsl.2018.12.002
PMID:30615845
Abstract

Pseudomonas aeruginosa (PA) is a bacterial pathogen that frequently displays antibiotic resistance. Its presence within the sinuses of chronic rhinosinusitis sufferers is associated with poorer quality of life. Obligately lytic bacteriophages (phages) are viruses that infect, replicate within, and lyse bacteria, causing bacterial death. The aims of this study were to assess the safety and efficacy of a PA phage cocktail (CT-PA) in a sheep model of rhinosinusitis. The sheep rhinosinusitis model was adapted to simulate PA infection in sheep frontal sinuses. To assess efficacy, after a 7-day biofilm formation period, sheep received twice-daily frontal trephine flushes of CT-PA or saline for 1 week. Biofilm quantitation on frontal sinus mucosa was performed using LIVE/DEAD BacLight staining. To assess safety, sheep received twice-daily frontal trephine flushes of CT-PA or vehicle control for 3 weeks. Blood and fecal samples were collected throughout treatment. Histopathology of frontal sinus, lung, heart, liver, spleen, and kidney tissue was performed. Sinus cilia were visualized using scanning electron microscopy (SEM). The Efficacy arm showed a statistically significant reduction in biofilm biomass with all concentrations of CT-PA tested (P < 0.05). Phage presence in sinuses was maintained for at least 16hours after the final flush. All Safety arm sheep completed 3 weeks of treatment. Phage was detected consistently in feces and sporadically in blood and organ samples. Histology and SEM of tissues revealed no treatment-related damage. In conclusion, CT-PA was able to decrease sinus PA biofilm at concentrations of 10-10 PFU/mL. No safety concerns were noted.

摘要

铜绿假单胞菌(PA)是一种经常表现出抗生素耐药性的细菌病原体。它存在于慢性鼻窦炎患者的鼻窦中,与生活质量较差有关。专性裂解噬菌体(噬菌体)是感染、在细菌内部复制并裂解细菌,导致细菌死亡的病毒。本研究的目的是评估 CT-PA 在绵羊鼻窦炎模型中的安全性和疗效。绵羊鼻窦炎模型经过改编,以模拟 PA 在绵羊额窦中的感染。为了评估疗效,在 7 天生物膜形成期后,绵羊接受了为期 1 周的每日两次额窦环钻冲洗 CT-PA 或生理盐水。使用 LIVE/DEAD BacLight 染色对额窦黏膜上的生物膜进行定量。为了评估安全性,绵羊接受了为期 3 周的每日两次额窦环钻冲洗 CT-PA 或载体对照。在整个治疗过程中采集血液和粪便样本。对额窦、肺、心脏、肝脏、脾脏和肾脏组织进行组织病理学检查。使用扫描电子显微镜(SEM)观察鼻窦纤毛。疗效组显示所有测试浓度的 CT-PA 均能显著降低生物膜生物量(P < 0.05)。噬菌体在鼻窦中的存在至少在最后一次冲洗后 16 小时内得以维持。所有安全组绵羊均完成了 3 周的治疗。噬菌体在粪便中持续存在,在血液和器官样本中偶尔存在。组织学和 SEM 显示没有与治疗相关的损伤。总之,CT-PA 能够在 10-10 PFU/mL 的浓度下降低鼻窦 PA 生物膜。未发现安全问题。

相似文献

1
Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis.一种噬菌体鸡尾酒在铜绿假单胞菌鼻窦炎体内模型中的安全性和疗效。
Transl Res. 2019 Apr;206:41-56. doi: 10.1016/j.trsl.2018.12.002. Epub 2018 Dec 19.
2
Activity of Bacteriophages in Removing Biofilms of Isolates from Chronic Rhinosinusitis Patients.噬菌体在清除慢性鼻窦炎患者分离株生物膜中的活性
Front Cell Infect Microbiol. 2017 Sep 22;7:418. doi: 10.3389/fcimb.2017.00418. eCollection 2017.
3
Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.局部应用噬菌体和乙二胺四乙酸治疗绵羊鼻窦炎模型中金黄色葡萄球菌感染的安全性和有效性
Int Forum Allergy Rhinol. 2014 Mar;4(3):176-86. doi: 10.1002/alr.21270. Epub 2014 Jan 21.
4
Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model.甲基乙二醛增强型麦卢卡蜂蜜作为一种局部抗金黄色葡萄球菌生物膜制剂:体内模型的安全性和有效性
Int Forum Allergy Rhinol. 2014 Mar;4(3):187-95. doi: 10.1002/alr.21264. Epub 2014 Jan 10.
5
Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus Region.局部应用噬菌体至额窦区域的长期安全性。
Front Cell Infect Microbiol. 2017 Feb 24;7:49. doi: 10.3389/fcimb.2017.00049. eCollection 2017.
6
Safety and Efficacy of Topical Chitogel- Deferiprone-Gallium Protoporphyrin in Sheep Model.局部应用几丁质凝胶-去铁酮-原卟啉镓在绵羊模型中的安全性和有效性
Front Microbiol. 2018 May 11;9:917. doi: 10.3389/fmicb.2018.00917. eCollection 2018.
7
Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis.NVC-422 对绵羊鼻窦炎生物膜模型中金黄色葡萄球菌生物膜的疗效。
Int Forum Allergy Rhinol. 2012 Jul-Aug;2(4):309-15. doi: 10.1002/alr.21038. Epub 2012 Mar 20.
8
Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis.噬菌体和溶菌酶在慢性鼻-鼻窦炎中的抗生物膜活性。
Acta Virol. 2021;65(2):127-140. doi: 10.4149/av_2021_203.
9
Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model.局部胶体银作为金黄色葡萄球菌慢性鼻窦炎绵羊模型中的抗生物膜剂。
Int Forum Allergy Rhinol. 2015 Apr;5(4):283-8. doi: 10.1002/alr.21459. Epub 2015 Jan 30.
10
A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.一种新型噬菌体鸡尾酒在静态和流动条件下可减少并分散铜绿假单胞菌生物膜。
Microb Biotechnol. 2016 Jan;9(1):61-74. doi: 10.1111/1751-7915.12316. Epub 2015 Sep 8.

引用本文的文献

1
Genomic variation in clinical respiratory isolates with resistance to a bacteriophage cocktail.对噬菌体鸡尾酒疗法耐药的临床呼吸道分离株中的基因组变异
Microbiol Spectr. 2025 May 6;13(5):e0214924. doi: 10.1128/spectrum.02149-24. Epub 2025 Mar 31.
2
Antibiotic Resistance of Strains-Searching for New Antimicrobial Agents-Review.菌株的抗生素耐药性——寻找新型抗菌剂——综述
Pharmaceuticals (Basel). 2025 Jan 11;18(1):81. doi: 10.3390/ph18010081.
3
Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics.
噬菌体疗法对体外伤口模型的作用及与β-内酰胺类抗生素联合使用的协同效应
Antibiotics (Basel). 2024 Aug 24;13(9):800. doi: 10.3390/antibiotics13090800.
4
Bacteriophages and Their Clinical Applications.噬菌体及其临床应用。
Viruses. 2024 Jun 29;16(7):1051. doi: 10.3390/v16071051.
5
A Novel Bacteriophage Infecting Multi-Drug- and Extended-Drug-Resistant Strains.一种感染多重耐药和广泛耐药菌株的新型噬菌体。
Antibiotics (Basel). 2024 Jun 3;13(6):523. doi: 10.3390/antibiotics13060523.
6
Evaluating the efficacy of a phage cocktail against Pseudomonas fluorescens group strains in raw milk: microbiological, physical, and chemical analyses.评价噬菌体鸡尾酒对生牛乳中荧光假单胞菌群菌株的功效:微生物学、物理学和化学分析。
Arch Microbiol. 2024 May 29;206(6):283. doi: 10.1007/s00203-024-04008-1.
7
Genomic and Proteomic Analysis of Six Vi01-like Phages Reveals Wide Host Range and Multiple Tail Spike Proteins.六株类似 Vi01 噬菌体的基因组和蛋白质组分析揭示了广泛的宿主范围和多种尾部刺突蛋白。
Viruses. 2024 Feb 13;16(2):289. doi: 10.3390/v16020289.
8
Bacteriophages-Dangerous Viruses Acting Incognito or Underestimated Saviors in the Fight against Bacteria?噬菌体——在与细菌的斗争中隐藏身份的危险病毒或被低估的救星?
Int J Mol Sci. 2024 Feb 9;25(4):2107. doi: 10.3390/ijms25042107.
9
Lytic activity of phages against bacterial pathogens infecting diabetic foot ulcers.噬菌体对感染糖尿病足溃疡的细菌病原体的裂解活性。
Sci Rep. 2024 Feb 12;14(1):3515. doi: 10.1038/s41598-024-53317-4.
10
Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens.噬菌体疗法:细菌感染管理方面的革命性转变,开创临床实践新视野,重塑对抗微生物病原体的武器库。
Front Med (Lausanne). 2023 Oct 19;10:1209782. doi: 10.3389/fmed.2023.1209782. eCollection 2023.